Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening

被引:46
作者
Chapman, RL
Stanley, TB
Hazen, R
Garvey, EP
机构
[1] GlaxoSmithKline, Dept Mol Screening, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Dept Gene Express & Prot Biochem, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Virol, Res Triangle Pk, NC 27709 USA
关键词
human immunodeficiency virus (HIV); Rev; rev response element (RRE); protein-RNA interaction; high throughput screening (HTS);
D O I
10.1016/S0166-3542(01)00222-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A high throughput scintillation proximity assay with biotinylated human immunodeficiency virus (HIV) Rev protein and tritiated Rev response element RNA was used to screen over 500 000 small molecules. Several chemical classes of inhibitors and two chemical classes of enhancers of binding were identified, with the molecular weight range being 400-600. The most common structural motif of inhibitor was an acidic moiety at the end of a linear aromatic system. Most of these modulators had EC50 values in the 1 - 10 muM potency range, with several below 1 muM. Several classes displayed structure-activity relationships suggesting specific molecular interactions between small molecule and macromolecule. Several molecules were confirmed as inhibitors in a gel shift assay and by surface plasmon resonance analysis. Furthermore, one inhibitor was shown to bind the Rev protein with a binding constant equal to its IC50 value, consistent with the mechanism of inhibition being binding Rev. Thus, small molecules can modulate this macromolecular protein-RNA interaction in vitro. However, no compound demonstrated HIV antiviral activity in a relevant cell-based assay. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:149 / 162
页数:14
相关论文
共 34 条
[1]   alpha helix-RNA major groove recognition in an HIV-1 Rev peptide RRE RNA complex [J].
Battiste, JL ;
Mao, HY ;
Rao, NS ;
Tan, RY ;
Muhandiram, DR ;
Kay, LE ;
Frankel, AD ;
Williamson, JR .
SCIENCE, 1996, 273 (5281) :1547-1551
[2]   SOLUTION OLIGOMERIZATION OF THE REV PROTEIN OF HIV-1 - IMPLICATIONS FOR FUNCTION [J].
COLE, JL ;
GEHMAN, JD ;
SHAFER, JA ;
KUO, LC .
BIOCHEMISTRY, 1993, 32 (44) :11769-11775
[3]   5-CHLORO-2',3'-DIDEOXY-3'-FLUOROURIDINE (935U83), A SELECTIVE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS AGENT WITH AN IMPROVED METABOLIC AND TOXICOLOGICAL PROFILE [J].
DALUGE, SM ;
PURIFOY, DJM ;
SAVINA, PM ;
STCLAIR, MH ;
PARRY, NR ;
DEV, IK ;
NOVAK, P ;
AYERS, KM ;
REARDON, JE ;
ROBERTS, GB ;
FYFE, JA ;
BLUM, MR ;
AVERETT, DR ;
DORNSIFE, RE ;
DOMIN, BA ;
FERONE, R ;
LEWIS, DA ;
KRENITSKY, TA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1590-1603
[4]   Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data [J].
Davis, TM ;
Wilson, WD .
ANALYTICAL BIOCHEMISTRY, 2000, 284 (02) :348-353
[5]   POTENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION BY AN INTRACELLULAR ANTI-REV SINGLE-CHAIN ANTIBODY [J].
DUAN, LX ;
BAGASRA, O ;
LAUGHLIN, MA ;
OAKES, JW ;
POMERANTZ, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :5075-5079
[6]   MOLECULAR WEIGHT OF AVIDIN [J].
GREEN, NM .
BIOCHEMICAL JOURNAL, 1964, 92 (02) :C16-&
[7]   NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein [J].
Hajduk, PJ ;
Dinges, J ;
Miknis, GF ;
Merlock, M ;
Middleton, T ;
Kempf, DJ ;
Egan, DA ;
Walter, KA ;
Robins, TS ;
Shuker, SB ;
Holzman, TF ;
Fesik, SW .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) :3144-3150
[8]   HIV-1 REGULATOR OF VIRION EXPRESSION (REV) PROTEIN BINDS TO AN RNA STEM-LOOP STRUCTURE LOCATED WITHIN THE REV RESPONSE ELEMENT REGION [J].
HEAPHY, S ;
DINGWALL, C ;
ERNBERG, I ;
GAIT, MJ ;
GREEN, SM ;
KARN, J ;
LOWE, AD ;
SINGH, M ;
SKINNER, MA .
CELL, 1990, 60 (04) :685-693
[9]   The ins and outs of HIV Rev [J].
Hope, TJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 365 (02) :186-191
[10]   RECOGNITION OF THE HIGH-AFFINITY BINDING-SITE IN REV-RESPONSE ELEMENT RNA BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV PROTEIN [J].
IWAI, S ;
PRITCHARD, C ;
MANN, DA ;
KARN, J ;
GAIT, MJ .
NUCLEIC ACIDS RESEARCH, 1992, 20 (24) :6465-6472